250 related articles for article (PubMed ID: 12376447)
21. Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation.
Singh PP; Singh M; Bedi U; Molnar J; Arora R; Khosla S
Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):23-31. PubMed ID: 21183532
[TBL] [Abstract][Full Text] [Related]
22. [Reduction of haemorrhagic risk in acute coronary syndromes].
Merino A; Roldán I; Marín F; Worner F;
Med Clin (Barc); 2011 Nov; 137(14):650-5. PubMed ID: 20701931
[No Abstract] [Full Text] [Related]
23. [Bleeding complications after treatment with antithrombotic agents after acute coronary syndrome].
Kristensen SD
Ugeskr Laeger; 2006 Sep; 168(38):3201. PubMed ID: 17026890
[No Abstract] [Full Text] [Related]
24. [Warfarin combined with blood platelet inhibition].
Vik-Mo H
Tidsskr Nor Laegeforen; 2011 Feb; 131(3):252-3. PubMed ID: 21304575
[TBL] [Abstract][Full Text] [Related]
25. [Acute coronary syndrome in patients using acetylsalicylic acid or warfarin].
Vik-Mo H; Hegbom K
Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1105-6. PubMed ID: 15114389
[No Abstract] [Full Text] [Related]
26. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
Wallén H; Agren A; Nekludov M
Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
[No Abstract] [Full Text] [Related]
27. Antithrombotic therapies in children on durable Ventricular Assist Devices: A literature review.
Huang JY; Monagle P; Massicotte MP; VanderPluym CJ
Thromb Res; 2018 Dec; 172():194-203. PubMed ID: 29501323
[TBL] [Abstract][Full Text] [Related]
28. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.
Yelnik CM; Lambert M; Drumez E; Le Guern V; Bacri JL; Guerra MM; Laskin CA; Branch DW; Sammaritano LR; Morel N; Guettrot-Imbert G; Launay D; Hachulla E; Hatron PY; Salmon JE; Costedoat-Chalumeau N
Lupus; 2018 Sep; 27(10):1679-1686. PubMed ID: 30016929
[TBL] [Abstract][Full Text] [Related]
29. [Antithrombotic agents].
Yamazaki M; Uchiyama S
Nihon Rinsho; 2012 Aug; 70 Suppl 6():231-8. PubMed ID: 23156514
[No Abstract] [Full Text] [Related]
30. Antithrombotic therapy and predilection for cerebellar hemorrhage.
Toyoda K; Okada Y; Ibayashi S; Inoue T; Yasumori K; Fukui D; Uwatoko T; Makihara N; Minematsu K
Cerebrovasc Dis; 2007; 23(2-3):109-16. PubMed ID: 17124390
[TBL] [Abstract][Full Text] [Related]
31. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
32. Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.
Ye S; Cheng B; Lip GY; Buchsbaum R; Sacco RL; Levin B; Di Tullio MR; Qian M; Mann DL; Pullicino PM; Freudenberger RS; Teerlink JR; Mohr JP; Graham S; Labovitz AJ; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Thompson JL; Homma S;
Am J Cardiol; 2015 Sep; 116(6):904-12. PubMed ID: 26189039
[TBL] [Abstract][Full Text] [Related]
33. Triple Antithrombotic Therapy in Patients With Left Ventricular Assist Devices.
Krim SR; Bennett A; Pfeffer M; Campbell PT; Thai S; Baetz B; Wever-Pinzon J; Eiswirth C; Desai S; Ventura HO
Curr Probl Cardiol; 2022 Aug; 47(8):100940. PubMed ID: 34384617
[TBL] [Abstract][Full Text] [Related]
34. Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis.
Hurlen M; Eikvar L; Seljeflot I; Arnesen H
Thromb Res; 2006; 118(4):433-8. PubMed ID: 16139331
[TBL] [Abstract][Full Text] [Related]
35. A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
Gianetti J; Gensini G; De Caterina R
Thromb Haemost; 1998 Dec; 80(6):887-93. PubMed ID: 9869155
[TBL] [Abstract][Full Text] [Related]
36. [Prevention of thrombosis with warfarin or acetylsalicylic acid related to the risk of hemorrhage].
Andersen P; Smith P; Ovrebø J
Tidsskr Nor Laegeforen; 1992 Mar; 112(9):1222-3. PubMed ID: 1579955
[No Abstract] [Full Text] [Related]
37. Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.
Pipilis A; Lazaros G; Tsakonas G; Stefanadis C
Hellenic J Cardiol; 2010; 51(4):330-7. PubMed ID: 20650831
[No Abstract] [Full Text] [Related]
38. The effect of antithrombotic drug use on delayed bleeding with esophageal endoscopic resection.
Horie Y; Horiuchi Y; Ishiyama A; Tsuchida T; Yoshimizu S; Hirasawa T; Fujisaki J; Maetani I; Yoshio T
J Gastroenterol Hepatol; 2022 Sep; 37(9):1792-1800. PubMed ID: 35844140
[TBL] [Abstract][Full Text] [Related]
39. Contemporary Use of Oral Antithrombotic Agents: Focus on Dual and Triple Therapeutic Approaches.
Jenkins AT; Kantorovich A; Burman L
Pharmacotherapy; 2017 Dec; 37(12):1545-1564. PubMed ID: 28981961
[TBL] [Abstract][Full Text] [Related]
40. Periprocedural management of antithrombotic therapy in hospitalized patients.
Feinbloom D
J Hosp Med; 2014 May; 9(5):337-46. PubMed ID: 24550198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
